Subject | Treatment group | Mean of NDI | Mean of % BiNC | Mean of % MultiNC | Mean per 1000 BiNC cells | Mean of % MNi in MoNC | ||
BiMNi | BiNPB | BiBuds | ||||||
Healthy volunteers | Untreated lymphocytes | 1.92±0.03 | 60.6±1.6 | 16.2±1.15 | 0.4±0.24 | 0 | 0 | 0 |
75 μM H2O2 | 1.96±0.03 | 60.6±0.4 | 18.4±1.56 | 12.2±1.11 | 0.2±0.2 | 0 | 6.2±1.59 | |
0.4 μM MMC | 1.88±0.06 | 59.2±2.4 | 15.6±3.81 | 18.0±2.09 | 0 | 0 | 8.4±1.8 | |
100 U·mL−1 IFN-γ | 1.87±0.02 | 58.8±0.58 | 14.2±1.2 | 1.4±0.24 | 0 | 0 | 1.2±0.37 | |
Blank liposome | 1.93±0.04 | 60.2±1.68 | 17.0±1.51 | 0.4±0.24 | 0 | 0 | 0 | |
IFN-γ liposome | 1.98±0.03 | 61.6±0.4 | 19.4±1.4 | 1.2±0.2 | 0 | 0 | 0.6±0.4 | |
IFN-γ liposome+H2O2 | 1.96±0.02 | 59.0±2.28 | 19.8±2.72 | 4.2±0.86 | 0 | 0 | 3.2±1.28 | |
IFN-γ+H2O2 | 1.92±0.07 | 59.6±1.91 | 17.6±4.45 | 4.8±0.96 | 0 | 0 | 4.4±1.43 | |
Lung cancer patients | Untreated lymphocytes | 1.90±0.03 | 58.4±2.2 | 16.4±1.43 | 7.4±0.6 | 0.2±0.2 | 0 | 3.4±0.4 |
75 μM H2O2 | 1.89±0.03 | 56.0±2.46 | 17.0±2.07 | 17.0±1.3 | 0.6±0.4 | 0 | 6.4±1.2 | |
0.4 μM MMC | 1.93±0.02 | 58.0±2.44 | 18.0±1.51 | 20.6±0.81 | 1.8±0.8 | 0.2±0.2 | 9±1.76 | |
100 U·mL−1 IFN-γ | 1.97±0.03 | 59.6±0.5 | 19.2±1.59 | 3.0±0.31 | 0 | 0 | 3±+0 | |
Blank liposome | 1.91±0.02 | 60.8±0.86 | 15.2±1.42 | 5.6±0.4 | 0.2±0.2 | 0 | 3.2±0.48 | |
IFN-γ liposome | 1.87±0.04 | 57.8±1.24 | 15.2±2.2 | 2.2±0.37 | 0 | 0 | 1.8±0.2 | |
IFN-γ liposome+H2O2 | 1.99±0.03 | 58.6±2.18 | 21.0±2.6 | 6.6±1.2 | 0 | 0 | 4±0.7 | |
IFN-γ+H2O2 | 1.98±0.03 | 61.0±1.34 | 18.6±1.56 | 8.6±0.92 | 0 | 0 | 5±1.37 |
NDI: nuclear division index; BiNC: binucleated cells; MultiNC: multinucleated cells; MoNC: mononucleated cells; MMC: Mitomycin C; IFN: interferon.